• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于尿嘧啶部分的新型乙酰胆碱酯酶抑制剂,可能用于治疗阿尔茨海默病。

Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease.

机构信息

Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of RAS, Arbuzov str. 8, 420088 Kazan, Russia.

Institute of Neuroscience, Kazan State Medical University, 420012 Kazan, Russia.

出版信息

Molecules. 2020 Sep 12;25(18):4191. doi: 10.3390/molecules25184191.

DOI:10.3390/molecules25184191
PMID:32932702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7571187/
Abstract

In this study, novel derivatives based on 6-methyluracil and condensed uracil were synthesized, namely, 2,4-quinazoline-2,4-dione with ω-(-nitrilebenzylethylamino) alkyl chains at the N atoms of the pyrimidine ring. In this series of synthesized compounds, the polymethylene chains were varied from having tetra- to hexamethylene chains, and secondary NH, tertiary ethylamino, and quaternary ammonium groups were introduced into the chains. The molecular modeling of the compounds indicated that they could function as dual binding site acetylcholinesterase inhibitors, binding to both the peripheral anionic site and active site. The data from in vitro experiments show that the most active compounds exhibit affinity toward acetylcholinesterase within a nanomolar range, with selectivity for acetylcholinesterase over butyrylcholinesterase reaching four orders of magnitude. In vivo biological assays demonstrated the potency of these compounds in the treatment of memory impairment using an animal model of Alzheimer disease.

摘要

在这项研究中,我们合成了基于 6-甲基尿嘧啶和稠合尿嘧啶的新型衍生物,即嘧啶环 N 原子上带有ω-(-氰基苯乙基氨基)烷基链的 2,4-喹唑啉-2,4-二酮。在这一系列合成的化合物中,聚亚甲基链的长度从四亚甲基到六亚甲基不等,并且在链中引入了仲 NH、叔乙氨基和季铵基团。化合物的分子建模表明,它们可以作为双结合位点乙酰胆碱酯酶抑制剂,与外周阴离子结合位点和活性位点结合。体外实验数据表明,最活跃的化合物对乙酰胆碱酯酶的亲和力在纳摩尔范围内,对乙酰胆碱酯酶的选择性比对丁酰胆碱酯酶的选择性高出四个数量级。体内生物学实验证明了这些化合物在使用阿尔茨海默病动物模型治疗记忆障碍方面的功效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/92e9cf3c750c/molecules-25-04191-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/da11f36b6a7e/molecules-25-04191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/dbba0d02630d/molecules-25-04191-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/ed4eb07e020c/molecules-25-04191-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/3b7eee5cc0ee/molecules-25-04191-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/0f876d44416b/molecules-25-04191-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/87e34c6d7dda/molecules-25-04191-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/a92aa31d4ae3/molecules-25-04191-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/92e9cf3c750c/molecules-25-04191-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/da11f36b6a7e/molecules-25-04191-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/dbba0d02630d/molecules-25-04191-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/ed4eb07e020c/molecules-25-04191-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/3b7eee5cc0ee/molecules-25-04191-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/0f876d44416b/molecules-25-04191-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/87e34c6d7dda/molecules-25-04191-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/a92aa31d4ae3/molecules-25-04191-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f7/7571187/92e9cf3c750c/molecules-25-04191-g005.jpg

相似文献

1
Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease.基于尿嘧啶部分的新型乙酰胆碱酯酶抑制剂,可能用于治疗阿尔茨海默病。
Molecules. 2020 Sep 12;25(18):4191. doi: 10.3390/molecules25184191.
2
6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.6-甲基尿嘧啶衍生物作为治疗阿尔茨海默病的双功能乙酰胆碱酯酶抑制剂
ChemMedChem. 2015 Nov;10(11):1863-74. doi: 10.1002/cmdc.201500334. Epub 2015 Sep 28.
3
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.新型基于尿嘧啶的乙酰胆碱酯酶抑制剂,具有治疗阿尔茨海默病动物模型记忆损伤的潜力。
Molecules. 2022 Nov 14;27(22):7855. doi: 10.3390/molecules27227855.
4
Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.新型N-苄基哌啶衍生物的合成:作为具有β-淀粉样蛋白抗聚集特性及对体内记忆有益作用的胆碱酯酶抑制剂
Bioorg Med Chem. 2015 May 15;23(10):2445-57. doi: 10.1016/j.bmc.2015.03.051. Epub 2015 Mar 27.
5
Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.发现新型 2,6-二取代哒嗪酮衍生物作为乙酰胆碱酯酶抑制剂。
Eur J Med Chem. 2013 May;63:95-103. doi: 10.1016/j.ejmech.2013.01.056. Epub 2013 Feb 8.
6
Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.基于药效基团、3D-QSAR 和分子对接方法评价新型双重乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂作为潜在的抗阿尔茨海默病药物。
Molecules. 2017 Jul 26;22(8):1254. doi: 10.3390/molecules22081254.
7
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.新型他克林-咔唑杂合物作为治疗阿尔茨海默病潜在多功能药物的合成、生物学评价及分子模拟研究
Eur J Med Chem. 2014 Mar 21;75:21-30. doi: 10.1016/j.ejmech.2014.01.020. Epub 2014 Jan 22.
8
Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.具有碘代苯甲酸部分的新型四氢吖啶衍生物作为多功能乙酰胆碱酯酶抑制剂。
Chem Biol Drug Des. 2018 Feb;91(2):505-518. doi: 10.1111/cbdd.13111. Epub 2017 Oct 24.
9
Design, synthesis, in vitro and in vivo evaluation of novel pyrrolizine-based compounds with potential activity as cholinesterase inhibitors and anti-Alzheimer's agents.新型吡咯烷类化合物的设计、合成、体外及体内评价,具有潜在的胆碱酯酶抑制作用和抗阿尔茨海默病活性。
Bioorg Chem. 2019 Dec;93:103312. doi: 10.1016/j.bioorg.2019.103312. Epub 2019 Sep 24.
10
Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice.发现一种具有抗氧化活性的乙酰胆碱酯酶和丁酰胆碱酯酶双重抑制剂,可减轻老年 APP/PS1 小鼠的阿尔茨海默病样病理。
J Med Chem. 2021 Jan 14;64(1):812-839. doi: 10.1021/acs.jmedchem.0c01775. Epub 2020 Dec 28.

引用本文的文献

1
Ionic and Non-Ionic Counterparts Based on Bis(Uracilyl)Alkane Moiety with Highest Selectivity Towards Acetylcholinesterase for Protection Against Organophosphate Poisoning and Treating Alzheimer's Disease.基于双(尿嘧啶基)烷烃部分的离子型和非离子型对应物,对乙酰胆碱酯酶具有最高选择性,用于预防有机磷中毒和治疗阿尔茨海默病。
Int J Mol Sci. 2025 Apr 16;26(8):3759. doi: 10.3390/ijms26083759.
2
Therapy of Organophosphate Poisoning via Intranasal Administration of 2-PAM-Loaded Chitosomes.通过鼻内给予负载2-吡啶醛肟甲基氯化物的壳聚糖微粒治疗有机磷中毒
Pharmaceutics. 2022 Dec 19;14(12):2846. doi: 10.3390/pharmaceutics14122846.
3
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.

本文引用的文献

1
The cytokine network in the pathogenesis of major depressive disorder. Close to translation?细胞因子网络在重度抑郁症发病机制中的作用。快要翻译完了吗?
Autoimmun Rev. 2020 May;19(5):102504. doi: 10.1016/j.autrev.2020.102504. Epub 2020 Mar 13.
2
The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease: Conventionally Pathogenetic or Unconventionally Protective?巨噬细胞移动抑制因子在阿尔茨海默病中的作用:传统上是发病机制还是非传统上的保护作用?
Molecules. 2020 Jan 10;25(2):291. doi: 10.3390/molecules25020291.
3
New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
新型基于尿嘧啶的乙酰胆碱酯酶抑制剂,具有治疗阿尔茨海默病动物模型记忆损伤的潜力。
Molecules. 2022 Nov 14;27(22):7855. doi: 10.3390/molecules27227855.
4
Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands.维生素 B6 二肟类似物作为胆碱酯酶配体的潜力。
Int J Mol Sci. 2022 Nov 2;23(21):13388. doi: 10.3390/ijms232113388.
5
Chemical Composition and Potential Properties in Mental Illness (Anxiety, Depression and Insomnia) of Agarwood Essential Oil: A Review.沉香精油的化学成分及其在精神疾病(焦虑、抑郁和失眠)中的潜在特性:综述。
Molecules. 2022 Jul 15;27(14):4528. doi: 10.3390/molecules27144528.
6
Benzobicyclo[3.2.1]octene Derivatives as a New Class of Cholinesterase Inhibitors.苯并双环[3.2.1]辛烯衍生物作为一类新型的胆碱酯酶抑制剂。
Molecules. 2020 Oct 22;25(21):4872. doi: 10.3390/molecules25214872.
新证据表明,乙酰胆碱酯酶双重结合位点抑制剂可作为治疗阿尔茨海默病的改良药物。
Neuropharmacology. 2019 Sep 1;155:131-141. doi: 10.1016/j.neuropharm.2019.05.025. Epub 2019 May 25.
4
Present Algorithms and Future Treatments for Alzheimer's Disease.阿尔茨海默病的现行算法和未来治疗方法。
J Alzheimers Dis. 2019;67(4):1157-1171. doi: 10.3233/JAD-180903.
5
Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.氧化应激、突触功能障碍与阿尔茨海默病
J Alzheimers Dis. 2017;57(4):1105-1121. doi: 10.3233/JAD-161088.
6
Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.作为双结合位点乙酰胆碱酯酶抑制剂的含N-苄基吡啶鎓部分的4-异苯并二氢吡喃酮杂合物的设计、合成、生物学评价及对接研究
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5212-6. doi: 10.1016/j.bmcl.2015.09.063. Epub 2015 Sep 28.
7
6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.6-甲基尿嘧啶衍生物作为治疗阿尔茨海默病的双功能乙酰胆碱酯酶抑制剂
ChemMedChem. 2015 Nov;10(11):1863-74. doi: 10.1002/cmdc.201500334. Epub 2015 Sep 28.
8
The genetic landscape of Alzheimer disease: clinical implications and perspectives.阿尔茨海默病的遗传图谱:临床意义与展望。
Genet Med. 2016 May;18(5):421-30. doi: 10.1038/gim.2015.117. Epub 2015 Aug 27.
9
Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents.新型大黄素衍生物的合成及多靶点生物活性评价作为治疗阿尔茨海默病的药物。
J Med Chem. 2014 Mar 27;57(6):2549-67. doi: 10.1021/jm401824w. Epub 2014 Mar 10.
10
Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.多靶点导向配体及其他治疗策略在阿尔茨海默病治疗中的探索。
Curr Neuropharmacol. 2014 Jan;12(1):2-36. doi: 10.2174/1570159X113116660047.